Related Experiment Video
Updated: Aug 18, 2026
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Patency of the infarct-related coronary artery and ventricular geometry
G A Lamas1, M A Pfeffer, E Braunwald
1Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Insights
Late reperfusion therapy after acute myocardial infarction (AMI) may improve left ventricular (LV) function by preserving normal LV geometry, independent of myocardial salvage. This suggests a potential "second time window" for beneficial interventions.
Area of Science:
- Cardiology
- Cardiovascular Research
- Medical Science
Background:
- Acute myocardial infarction (AMI) pathogenesis involves coronary artery thrombosis.
- Early reperfusion aims for myocardial salvage within a narrow time window.
- Late reperfusion may offer benefits beyond myocardial salvage.
Purpose of the Study:
- Investigate the potential benefits of late reperfusion in AMI.
- Explore the role of preserving left ventricular (LV) geometry.
- Identify mechanisms for improved prognosis independent of myocardial salvage.
Main Methods:
- Review of pathogenesis and experimental data on infarct expansion.
- Analysis of factors influencing LV geometry and dilation.
- Hypothesizing potential therapeutic strategies for late intervention.
Main Results:
- Late thrombolysis appears to improve LV function and prognosis.
- Preservation of normal LV geometry by reducing infarct expansion is a key mechanism.
- Anterior wall AMI with persistent occlusion is associated with pronounced infarct expansion and LV dilation.
Conclusions:
- A late,
- second time window
- may exist for reducing infarct expansion and LV geometry distortion.
- Therapies like late thrombolysis, mechanical reperfusion (PTCA), and load-reducing agents warrant investigation.
Abstract:
The pathogenesis of acute myocardial infarction (AMI) involves a sudden thrombotic occlusion of a coronary artery. Spontaneous or pharmacologic thrombolysis may lead to myocardial salvage if patency is achieved within a narrow time window. However, patients in whom thrombolysis occurs late seem to demonstrate improved left ventricular (LV) function and prognosis, which may be independent of myocardial salvage. Preservation of normal LV geometry by reducing expansion of the infarcted segment is a likely mechanism for this benefit. Infarct expansion is most pronounced in patients with anterior wall AMI who have a persistently occluded infarct-related vessel. This process of expansion leads to early increases in LV volume and distortions of LV contour (abnormal LV geometry). Patients whose infarct segment is largest, patients who have manifested infarct expansion, and patients with a persistently occluded infarct-related artery are at highest risk for progressive LV dilation. Experimental data support the concept that reperfusion of occluded vessels that occurs too late for myocardial salvage will preserve LV geometry by limiting infarct expansion. Prospective clinical trials should address whether there is a late, "second time window" during which infarct expansion and distortions of LV geometry may be reduced by (1) therapy with thrombolytic agents applied late after infarction, (2) late mechanical reperfusion with percutaneous transluminal coronary angioplasty (PTCA) or related methods, and (3) load-reducing agents to decrease remodeling, such as angiotensin-converting enzyme inhibitors or nitroglycerin.
